The Future in Treating
Designed to treat Acute Limb Ischemia (ALI), organized thrombus and other embolic/thrombotic events
ICHOR has developed a one size fits all system that replicates the parameters of surgical embolectomy with reduced surgical or drug complications, no blood loss to aspiration, reduced bleeding complications associated with drug therapy, and eliminates the need for general anesthesia. The technology is easily adoptable by interventionalists, incorporates health economics, and specifically designed to make ICHOR a first line therapy for physicians and hospitals.
Pulse MED: Improved Blood Clot Dissolution
Nano-technology designed to target non-invasive therapy in Acute Ischemic Stroke (AIS) and other vascular occlusions
Pulse MED™ is an iron based nanoparticle influenced by external magnetic power designed to treat and diagnose conditions current technologies cannot reach. The nano size and magnetic power source can target non-invasive therapy into common diseased vasculature as well as the deepest and smallest vascular beds today’s technologies cannot even explore. This novel platform nano-technology will diagnose and/or treat a wide array of vascular occlusions in a way that is elegant yet revolutionary for physicians and patients.
In stroke, a blood vessel becomes obstructed. When the clot-busting drug is administered, the challenge is getting the medicine where it needs to go. Pulses MED™ (Magnetically-Enhanced Diffusion) overcomes this barrier with a process that may be significantly faster in reaching clots, and as a result, more effective in treating strokes.
Safe and effective products to treat vascular occlusions and achieve reperfusion
Minimally invasive systems easily adoptable by physicians, hospitals, and office based labs
Reduces or eliminates surgical and drug complications
Technologies aimed at transforming outcomes and the economics in treating vascular occlusions
Leading scientific advisory board and team.
Novel technologies with 5 U.S. patents, 3 International patents, and several patents pending.
Completed National Institute of Health (NIH) Milestones, recently awarded several new NIH study grants.
Euphrates Vascular’s ICHOR Percutaneous Reperfusion System is included in EV Today’s Device Guide for Mechanical Thrombectomy/Thrombolysis. This helpful buyer’s guide includes: Sheath compatibilityGuidewire compatibilityWorking lengthMode of operationUS FDA indicated use View EV Today’s Thrombectomy GuideRead More